Professional Documents
Culture Documents
Table 1. Number of pregnant women from each ethnic group whose parathyroid hormone, calcium, phosphate and alkaline
vitamin D was tested and percentage treated. phosphatase from women on supplements, and their general
Ethnic origin No. of women Percentage treated practitioners notified if further supplementation was neces-
sary. Every effort was made to improve compliance.
Indian subcontinent 100 52
Besides providing written information, the midwives also
Afro-Caribbean 4 25
Middle East 9 22 made it a point to remind women to take supplements at
Far East 11 9 each visit, be it in hospital or at home.
Africa 36 67
RESULTS
Parathyroid hormone was measured by an immuno-
chemiluminometric assay (Magic Lite PTH; Chiron Diag- One hundred and sixty consecutive pregnant women
nostics, Halstead, Essex, UK). The inter-assay coefficient were recruited from ethnic minority groups. Eighty women
of variation at a concentration of 43.6 pmol/L was 11.3%. (50%) had vitamin D levels <8 ng/mL and were treated
25-Hydroxycholecalciferol was measured by radio- with oral vitamin D. Table 1 shows the percentage of
immunoassay (Incstar, MN 55082, USA). The inter-assay treated women from each ethnic group.
coefficient of variation at a concentration of 53.7 ng/mL Figure 1 shows the relationship between parathyroid
was 11.0%. hormone and vitamin D levels in 144 women at booking.
A vitamin D level <8 ng/mL (<20 nmol/L) was taken as While parathyroid hormone was elevated in some women
the cutoff value for commencing calciferol 800 IU/day. At with presumed vitamin D deficiency, 65 of the 80 women
36 weeks, all women with low or borderline vitamin D (81%) with low vitamin D levels had parathyroid hormone
levels were re-tested and if the levels still remained unsat- levels within the normal adult reference range (<5.6 pmol).
isfactory, the supplements were increased to 1600 IU/day. Vitamin D and parathyroid hormone levels were
Finally, at delivery, blood was taken for vitamin D, rechecked at delivery in 58 of the 80 women (73%).
30
20
10
9
8
Vitamin. D at booking
7
6
4
.6 .8 1 2 4 6 8 10 20 40
Parathyroid hormone at
booking
Fig. 1. Levels of serum parathyroid hormone and vitamin D at booking in 144 women.
Table 2. Serum vitamin D and parathyroid hormone levels at delivery in 400– 1000 IU/day of vitamin D for those that are found
58 out of 80 women who were treated with oral vitamin D supplements
to be deficient seems safe21. However, this policy requires
during pregnancy.
good compliance. Poor compliance is reflected in our
Vitamin D Vitamin D Parathyroid hormone study, as vitamin D levels returned to normal only in 35
at booking post-delivery out of 58 women who were tested at delivery.
At booking Post-delivery
Controversy still exists regarding the effects of preg-
Mean 5.79 11.24 3.69 4.06 nancy on circulating maternal parathyroid hormone levels
SD 0.91 6.34 2.78 3.17 and its value as a screening test. Although there is now
considerable data indicating that plasma levels of para-
thyroid hormone rise with poor vitamin D status, this may
The mean level of vitamin D increased from 6 to 11 Ag/mL, not be true for pregnancy. Studies using a new immuno-
but the mean parathyroid hormone level remained the same radiometric assay for parathyroid hormone have reported
(Table 2). a decline in parathyroid hormone levels during preg-
Vitamin D levels returned to normal in 35 of the 58 nancy22,23. Circulating levels of 1,25-dihydroxycholecalci-
women (60%) checked at delivery. It was not possible to ferol have consistently been shown to be elevated during
ascertain the compliance of the women. In all the 58 pregnancy due to placental synthesis24,25, and this hormone
women, the calcium, phosphate and alkaline phosphatase has been suggested as the primary mediator of changes in
levels were within normal limits. maternal calcium metabolism. Our study also demonstrated
Other factors influencing vitamin D status such as a weak association between plasma levels of parathyroid
religion, fluency in English and dressing habits did not hormone and vitamin D (Fig. 1). This has been reported
appear to affect vitamin D levels. However, 50% of the previously26,27 and suggests that circulating parathyroid
women who had been in Britain for longer than three years hormone on its own is inappropriate as a test of vitamin D
had subnormal vitamin D levels, compared with 25% of status during pregnancy. Hence, it seems that both
those who have lived in Britain for less than three years and vitamin D as well as parathyroid hormone levels should
25% of those who were born in Britain. be estimated in order to screen for vitamin D deficiency
during pregnancy.
In the 1970s, several studies suggested how best to
DISCUSSION improve vitamin D status in Asian mothers and their
newborn infants living in Britain. Brooke et al.3, in a
Our findings confirm results from an earlier study double-blind trial of vitamin D supplements in pregnant
showing a large number of women from ethnic minority Asian women, administered 1000 units of ergocalciferol
populations in the Cardiff area to be subclinically defi- per day to 59 women and placebo to 67 controls during
cient in vitamin D8. The same was not found in pregnant, the last trimester. Mothers in the treatment group gained
white, Caucasian women. Although low vitamin D status weight faster and at term they and their infants all had
seldom causes florid maternal osteomalacia9 – 12, it has adequate plasma 25-hydroxycholecalciferol concentra-
been associated with maternal ill health especially during tions; infants in the control group had larger fontanelles,
pregnancy and lactation, with symptoms including muscle and five had symptomatic hypocalcaemia. The same
and joint pains, poor appetite and general apathy and workers also demonstrated improved postnatal growth
weakness, as well as neonatal rickets with fits and in infants whose mothers received a supplement of
stridor7, hypocalcaemia13,14, heart disease15, slow growth vitamin D16,17.
during the first year of life3,16,17 and hypoplasia of the The Department of Health5,20 has recommended that
enamel of primary teeth18. Hence, it seems prudent to measures should be taken to improve awareness among
give vitamin D supplementation to all pregnant women the public as well as doctors and midwives regarding the
from ethnic minorities. This has been the recommendation need to achieve adequate vitamin D status during preg-
of the Department of Health for more than 20 years, nancy in women from ethnic minorities. We undertook our
although it is not widely practised. interventional project in the light of evidence of poor
Vitamin D is toxic in large doses. Cases of hypervitami- compliance from several previous studies. Screening these
nosis D have been reported in individuals whose vitamin D women during their first antenatal visit with subsequent
intake was 70 – 600 times higher than the recommended supplementation where appropriate seems a satisfactory
400 IU/day19, but there have also been cases of infantile and safe approach.
hypercalcaemia caused by a moderate increase in vitamin D
intake20. It seems justified to screen all individuals before
supplementation. Acknowledgements
More research is needed to establish the most accept-
able, efficient and cost-effective way of vitamin D sup- We thank Mrs Hayley Phillips for administrative super-
plementation. Nevertheless, daily supplementation with vision throughout the study.
D RCOG 2002 Br J Obstet Gynaecol 109, pp. 905 – 908
908 S. DATTA ET AL.